Your browser is no longer supported. Please, upgrade your browser.
Settings
ATHA [NASD]
Athira Pharma, Inc.
Index- P/E- EPS (ttm)- Insider Own0.90% Shs Outstand35.78M Perf Week-1.29%
Market Cap375.09M Forward P/E- EPS next Y-2.09 Insider Trans0.00% Shs Float35.49M Perf Month-6.42%
Income- PEG- EPS next Q-0.34 Inst Own73.00% Short Float3.71% Perf Quarter-51.78%
Sales- P/S- EPS this Y-915.40% Inst Trans2.95% Short Ratio1.05 Perf Half Y-54.16%
Book/sh10.15 P/B0.98 EPS next Y-48.20% ROA- Target Price- Perf Year-
Cash/sh8.04 P/C1.23 EPS next 5Y- ROE- 52W Range9.22 - 34.79 Perf YTD-71.07%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-71.23% Beta-
Dividend %- Quick Ratio69.30 Sales past 5Y- Gross Margin- 52W Low8.57% ATR0.64
Employees20 Current Ratio69.30 Sales Q/Q- Oper. Margin- RSI (14)39.52 Volatility6.26% 6.77%
OptionableYes Debt/Eq0.00 EPS Q/Q-50.90% Profit Margin- Rel Volume0.21 Prev Close9.91
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.25M Price10.01
Recom1.50 SMA20-2.37% SMA50-27.19% SMA200-50.06% Volume243,721 Change1.01%
Oct-13-20Initiated Stifel Buy $36
Oct-13-20Initiated JMP Securities Mkt Outperform $51
Oct-13-20Initiated Jefferies Buy $30
Oct-13-20Initiated Goldman Buy $53
Aug-03-21 03:00PM  
02:50PM  
12:00PM  
12:00PM  
10:10AM  
10:06AM  
10:00AM  
09:30AM  
09:00AM  
Aug-02-21 10:50PM  
08:21PM  
02:10PM  
01:45PM  
01:05PM  
11:05AM  
09:40AM  
09:08AM  
05:50AM  
Aug-01-21 01:21PM  
11:15AM  
10:35AM  
Jul-31-21 12:15PM  
10:40AM  
10:04AM  
Jul-30-21 10:50PM  
08:40PM  
07:50PM  
07:10PM  
05:40PM  
02:00PM  
01:30PM  
12:22PM  
10:15AM  
09:46AM  
09:30AM  
09:22AM  
Jul-29-21 09:09PM  
07:03PM  
05:30PM  
12:40PM  
12:16PM  
12:15PM  
10:45AM  
09:22AM  
Jul-28-21 11:03PM  
10:50PM  
08:40PM  
08:00PM  
04:05PM  
02:35PM  
01:15PM  
11:00AM  
09:36AM  
09:15AM  
06:00AM  
Jul-27-21 10:50PM  
05:31PM  
04:10PM  
04:00PM  
02:50PM  
02:45PM  
01:00PM  
12:15PM  
09:32AM  
09:30AM  
09:13AM  
12:50AM  
Jul-26-21 10:50PM  
09:30PM  
05:50PM  
05:27PM  
03:22PM  
02:05PM  
01:45PM  
12:18PM  
11:30AM  
11:00AM  
09:09AM  
12:10AM  
Jul-25-21 12:41PM  
11:30AM  
11:10AM  
11:00AM  
10:33AM  
Jul-24-21 08:33PM  
Jul-23-21 10:50PM  
09:55PM  
08:31PM  
01:30PM  
01:15PM  
12:40PM  
10:50AM  
09:45AM  
09:45AM  
09:30AM  
09:20AM  
05:40AM  
Jul-22-21 10:41PM  
08:29PM  
04:46PM  
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD Phase II/III and ACT-AD Phase II clinical trials for the treatment of mild-to-moderate Alzheimer's disease, as well as in clinical development for Parkinson's disease. The company also develops product candidates, which are in preclinical stage, including ATH-1019/ATH-1020 for neuropsychiatric conditions; and ATH-1018 for peripheral nervous system disorders, such as neuropathy. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOEBIUS HANSChief Medical OfficerJul 21Option Exercise1.3528,37238,30230,427Jul 21 04:47 PM
MILESON GLENNAChief Financial OfficerJun 10Option Exercise1.356,3058,51289,824Jun 10 06:48 PM
CHURCH KEVINVice President of DiscoveryJun 08Option Exercise1.043,1523,27844,133Jun 09 05:39 PM
FLUKE JOHN M JRDirectorFeb 03Option Exercise1.2129,00335,119143,884Feb 04 08:18 PM
PERCEPTIVE ADVISORS LLCDirectorJan 25Buy22.50311,1116,999,9983,425,916Jan 27 05:43 PM